相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mathematical model of blood and interstitial flow and lymph production in the liver
Jennifer H. Siggers et al.
BIOMECHANICS AND MODELING IN MECHANOBIOLOGY (2014)
Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction Data
H. J. Einolfl et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Understanding and preventing drug-drug and drug-gene interactions
Cara Tannenbaum et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro
A. Dash et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
A mechanistic physiologically based pharmacokinetic-enzyme turnover model involving both intestine and liver to predict CYP3A induction-mediated drug-drug interactions
Haifang Guo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
A physiologically-based flow network model for hepatic drug elimination I: regular lattice lobule model
Vahid Rezania et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2013)
Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models
Eleanor J. Guest et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Physiologically Based Pharmacokinetic Modeling of Intestinal First-Pass Metabolism of CYP3A Substrates with High Intestinal Extraction
Michael Gertz et al.
DRUG METABOLISM AND DISPOSITION (2011)
Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Sara K. Quinney et al.
DRUG METABOLISM AND DISPOSITION (2010)
Theoretical Considerations on Quantitative Prediction of Drug-Drug Interactions
Akihiro Hisaka et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-The effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Simulating Microdosimetry in a Virtual Hepatic Lobule
John Wambaugh et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2009)
Prediction of drug distribution within blood
Paulo Paixao et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Impact of Hepatic Uptake Transporters on Pharmacokinetics and Drug-Drug Interactions: Use of Assays and Models for Decision Making in the Pharmaceutical Industry
Mathew G. Soars et al.
MOLECULAR PHARMACEUTICS (2009)
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes
Stuart W. Paine et al.
DRUG METABOLISM AND DISPOSITION (2008)
Prediction of drug-drug interactions from in vitro induction data - Application of the relative induction score approach using cryopreserved human hepatocytes
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2008)
A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
Odette A. Fahmi et al.
DRUG METABOLISM AND DISPOSITION (2008)
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
Shiew-Mei Huang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance
Hayley S. Brown et al.
DRUG METABOLISM AND DISPOSITION (2007)
Pharmacokinetic drug interactions involving 17 alpha-ethinylestradiol - A new look at an old drug
Hongjian Zhang et al.
CLINICAL PHARMACOKINETICS (2007)
Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole
Jenny Y. Chien et al.
DRUG METABOLISM AND DISPOSITION (2006)
Comparison of midazolam and simvastatin as cytochromc P450 3A probes
E Chung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: Comparison of a milk thistle and black cohosh product to rifampin and clarithromycin
B Gurley et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions
RS Obach et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes
RJ Riley et al.
DRUG METABOLISM AND DISPOSITION (2005)
Adverse drug reactions in elderly patients
PA Routledge et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Validated assays for human cytochrome P450 activities
RL Walsky et al.
DRUG METABOLISM AND DISPOSITION (2004)
Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver
ZE Wilson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes
K Ito et al.
DRUG METABOLISM AND DISPOSITION (2003)
Formation of steady-state oxygen gradients in vitro - Application to liver zonation
JW Allen et al.
BIOTECHNOLOGY AND BIOENGINEERING (2003)
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone
YWF Lam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model
S Björkman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1′-hydroxylation
S Palovaara et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Carrier-mediated transport of macrolide antimicrobial agents across Caco-2 cell monolayers
H Saito et al.
PHARMACEUTICAL RESEARCH (2000)
Oxygen: Modulator of metabolic zonation and disease of the liver
K Jungermann et al.
HEPATOLOGY (2000)
分享论文
